Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $2,919 - $4,008
16 New
16 $3,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $3,878 - $5,745
-19 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$249.67 - $299.48 $749 - $898
-3 Reduced 13.64%
19 $6,000
Q2 2020

Jul 15, 2020

BUY
$118.84 - $189.72 $2,614 - $4,173
22 New
22 $4,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.